Ads
related to: drug patent expirations
Search results
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 2 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Novartis loses in patent appeal over multiple sclerosis drug
Reuters via Yahoo News· 2 years ago(Reuters) -A U.S. appeals court on Tuesday ruled that a patent related to Swiss drugmaker Novartis...
Exelixis (EXEL) Reports Positive EU Patent Ruling for Cabometyx
Zacks via Yahoo Finance· 4 months agoExelixis, Inc. EXEL announced that it has successfully defended an EU patent for Cabometyx...
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 month agoBiogen Inc's robust product portfolio and pipeline offer a competitive edge in the neurology and immunology sectors. Despite a slight revenue dip, Biogen...
How an Innovative Deal Will Give Millions Access to Cheaper Tuberculosis Drugs
Time via Yahoo News· 11 months agoWhy a new deal between Johnson & Johnson and the non-profit Global Drug Facility means that the...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 1 month agoThe pharmaceutical industry has been a whirlwind of highs and lows for investors over the past two decades. The high-risk, high-reward nature of drug...
Novartis (NVS) to Appeal to Supreme Court for Gilenya Patent
Zacks via Yahoo Finance· 2 years agoNovartis (NVS) is looking to defend its patents for the multiple sclerosis drug Gilenya and file a...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 1 month agoRegeneron stock jumped Thursday, bolstered by strong sales of a high-dose version of its blockbuster...
2 Best Biotech Stocks to Buy Right Now
Motley Fool· 1 year agoSuccessful investing depends on the ability to both accurately read the present and extrapolate the future. In other words, you need to gauge where a...
Pfizer sees $10 billion-$15 billion in potential revenue from mRNA vaccines by 2030
Reuters via Yahoo News· 1 year agoIn November, Pfizer had raised its forecast for 2022 sales of its COVID-19 vaccine by $2 billion to...
